CAS编号 | 1612838-76-2 |
抗体名 | Risankizumab ( 利散吉珠单抗 ) |
靶点 | IL23A[Homo sapiens] |
纯度 | % |
产地 | 中国 |
品牌 | Chemstan |
货号 | CS00400 |
保存条件 | store at -80℃ |
抗原来源 | CHO cells |
保质期 | 一年 |
规格 | 100μg |
产品用途 | 仅用于科研用途 |
浓度 | 95% |
是否进口 | 否 |
货号(Catalog No.)
CSD00400
通用名INN
Risankizumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Risankizumab is a fully humanized IgG1 monoclonal antibody (mAb) that is selective for interleukin 23 (IL-23). On April 23, 2019 it was approved by the FDA (as SKYRIZI) for the treatment of moderate-to-severe plaque psoriasis in adults who are clinically considered eligible for systemic therapy or phototherapy for psoriasis.Label This drug has been commercialized through collaboration between the German pharmaceutical company, Boehringer Ingelheim, and Abbvie.
别名(Alternative names)
BI 655066,risankizumab-rzaa
靶点;物种(Specificity target name;species)
IL23A[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG1-kappa
化学信息
CAS
1612838-76-2
存储条件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .
15926423062
武汉科斯坦生物科技有限公司 版权所有(C)2024 XML 技术支持: 盖德化工网 食品商务网
武汉科斯坦生物科技有限公司